Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide-Reference-Cited by-同舟云学术

Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide

Published:2020-09-15 Issue:12 Volume:27 Page:1109-1115
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Shiota Masaki¹,Machidori Asako¹,Abe Tatsuro¹,Monji Keisuke¹,Kashiwagi Eiji¹,Takeuchi Ario¹,Takahashi Ryosuke¹,Inokuchi Junichi¹,Yokomizo Akira²,Naito Seiji²,Eto Masatoshi¹

Affiliation:

1. Department of Urology Graduate School of Medical Sciences Kyushu University FukuokaJapan

2. Department of Urology Harasanshin Hospital Fukuoka Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14366

Reference28 articles.

1. Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome

2. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.

3. Bone Alkaline Phosphatase Serum Level Predicts the Response to Antiandrogen Withdrawal

4. Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer

5. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-Line Treatment After the Failure of Androgen Deprivation Therapy for Non-Metastatic, Castration-Resistant Prostate Cancer Men;International Journal of Pharmacology;2022-04-15

2. Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors;JMA Journal;2022

3. Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer;Prostate International;2021-10